Zevra Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	106.47	23.61	27.46	10.46	28.65
Revenue Growth (YoY)	350.92%	-14.02%	162.58%	-63.50%	115.61%
Cost of Revenue	16.48	7.42	2.17	0.34	2.06
Gross Profit	89.99	16.2	25.29	10.12	26.59
Selling, General & Admin	77.62	54.87	34.31	15.34	8.7
Depreciation & Amortization Expenses	3.86	6.24	0.77	-	-
Research & Development	12.74	42.1	39.81	37.28	10.16
Other Operating Expenses	58.71	-	-	-	-
Total Operating Expenses	152.93	103.2	74.89	52.62	18.86
Operating Income	-62.94	-87	-49.6	-42.51	7.73
Interest Income	6.95	2.18	4.54	0.76	0.26
Interest Expense	-7.98	-7.35	-1.5	-0.34	-0.38
Other Non-Operating Income (Expense)	150.65	2.04	0.52	-0.25	-16.14
Total Non-Operating Income (Expense)	149.62	-3.14	3.56	0.18	-16.25
Pretax Income	86.68	-90.14	-46.05	-42.33	-8.52
Provision for Income Taxes	-3.45	-15.37	-	0.79	-0.03
Net Income	83.23	-105.51	-46.05	-41.54	-62.9
Net Income Attributable to Preferred Dividends	-	-	-	-	54.34
Net Income to Common	83.23	-105.51	-46.05	-41.54	-62.9
Shares Outstanding (Basic)	55	46	35	34	30
Shares Outstanding (Diluted)	57	46	35	34	30
Shares Change (YoY)	23.81%	30.46%	2.79%	15.87%	647.72%
EPS (Basic)	1.40	-2.28	-1.30	-0.78	-2.11
EPS (Diluted)	1.35	-2.28	-1.30	-0.78	-2.11
Free Cash Flow	-2.43	-69.67	-33.83	-18.81	10.34
Free Cash Flow Per Share	-0.04	-1.51	-0.95	-0.55	0.35
Gross Margin	84.52%	68.59%	92.09%	96.72%	92.81%
Operating Margin	-59.12%	-368.47%	-180.63%	-406.44%	26.98%
Profit Margin	78.17%	-446.85%	-167.69%	-397.24%	-29.86%
FCF Margin	-2.29%	-295.04%	-123.20%	-179.86%	36.08%
EBITDA	-58.89	-80.61	-48.6	-41.56	7.99
EBITDA Margin	-55.31%	-341.41%	-176.97%	-397.41%	27.87%
EBIT	-62.94	-87	-49.6	-42.51	7.73
EBIT Margin	-59.12%	-368.47%	-180.63%	-406.44%	26.98%
Effective Tax Rate	-3.98%	17.05%	0.00%	-1.86%	0.40%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q